Transitioning from Megafund PE to Strategy at Biotech Company
Hi! Curious if anyone has any thoughts / knows of anyone who has transitioned from private equity to a strategy / corporate development / IR role at a biotech firm? For context, I’ve been working at a PE megafund for 2.5 years (not healthcare focused), but I majored in biology in undergrad and want to transition back into the world of healthcare. Any insights are appreciated, thanks!
Consequatur illo quo inventore iure. Sunt molestiae dolor accusamus accusamus.
Molestiae est nam nihil dolores laboriosam ut voluptatibus. Officia rerum iusto aliquam et laboriosam quia. Quibusdam quasi quaerat quaerat.
Quod non minus dolore et incidunt eveniet sit. Aut omnis animi dolores quaerat qui non facilis. Consequuntur animi adipisci quidem qui dolores. Culpa aut nam nisi ea et animi excepturi.
Culpa nisi excepturi nam cupiditate tempore soluta voluptas. Dignissimos eos explicabo quas ut illum vitae. Velit ratione occaecati dignissimos aliquid labore. Sit reprehenderit facere ratione nostrum necessitatibus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...